Institutional Ownership
Bridgebio Pharma Inc
CUSIP 10806X102COMBBIOQ1 2026
Institutional Holders
449
13F filers
Shares Held
177.37M
Aggregate institutional
Institutional Value
$12.64B
Q1 2026
Net New Holders
+28
79 new · 51 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions79
Increased181
Decreased133
Sold out51
Institutional Holders
449 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 14.21M | $1.06B | −341.8K | Reduced |
| 2 | Kohlberg Kravis Roberts & Co. L.P. | 13.26M | $984.76M | 0 | Held |
| 3 | Janus Henderson Group PLC | 13.18M | $978.61M | +2.18M | Added |
| 4 | Viking Global Investors LP | 11.84M | $879.42M | −2.55M | Reduced |
| 5 | Farallon Capital Management LLC | 9.37M | $695.48M | +9.37M | New |
| 6 | Aisling Capital Management LP | 5.09M | $377.95M | 0 | Held |
| 7 | Geode Capital Management, LLC | 4.92M | $371.93M | +505.5K | Added |
| 8 | State Street Corp | 4.93M | $366.42M | −28.5K | Reduced |
| 9 | Invesco Ltd. | 4.59M | $341.06M | −238.5K | Reduced |
| 10 | Frazier Life Sciences Management, L.P. | 3.45M | $256.06M | −97.4K | Reduced |
439 more institutional holders on Premium
See every fund holding Bridgebio Pharma Inc, with full quarter-over-quarter share changes.
Unlock all holders